David Loew swaps Sanofi’s top vaccine job for CEO role at Ip...

Sanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as the new chief executive of French specialty drugmaker Ipsen, taking over

Engaging with customers in a digital world

As part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains the many ways digital can enhance the customer journey – so long as t

Ipsen craters as pricey rare disease drug is put on hold aga...

Allergan gets FDA okay for paediatric Botox use

Ipsen adds Blueprint's FOP rare disease drug to pipeline for...

Ipsen has added to its rare diseases pipeline after striking an agreement with US biotech Blueprint for a  licence to develop and market a drug for the rare disease fibrodysplasia ossifican